Metabolic Syndrome as a Risk Factor for Developing Benign Prostatic Hyperplasia-A Simple, Non-invasive Method of Transabdominal Ultrasonography for BPH-

• IIZUKA Takashi

  <I>Asahi Medical Clinic, Department of Urology</I>

• SUZUKI Makiko

  <I>Asahi Medical Clinic, Department of Urology</I>

• MINAMIYAMA Nana

  <I>Asahi Medical Clinic, Department of Urology</I>

• ANDO Akemi

  <I>Asahi Medical Clinic, Department of Urology</I>

• KURAMOTO Chie

  <I>Asahi Medical Clinic, Department of Urology</I>

• KUWABARA Takeo

  <I>Asahi Medical Clinic, Department of Urology</I>

• YAMAGUCHI Kunio

  <I>Yokohama Rosai Hospital, Department of Urology</I>

書誌事項

タイトル別名

• —A Simple, Non-invasive Method of Transabdominal Ultrasonography for BPH—

抄録

The aim of this study was to clarify the effects of metabolic syndrome on benign prostatic hyperplasia (BPH) by use of transabdominal ultrasonography in healthy males, the subjects of this study were 333 Japanese men. All subjects were divided to two groups; 146 subjects in the smaller group (prostatic anteroposterior size<28.0 mm, mean age; 45.3yrs) and 187 subjects in the larger group (prostatic anteroposterior size ≥28.0 mm, mean age; 51.3yrs), respectively. The levels of age, systolic blood pressure (S-BP), diastolic blood pressure (D-BP), fasting insulin (FIRI), plasma triglyceride (TG), γ-glutamyltranspeptidase (γ-GPT), Fe, plasma prostate-special antigen (PSA), insulin resistance (HOMA-IR) and pancreas β cell function (HOMA-β) were significantly higher in the larger group than those in the smaller group, however plasma high density lipoprotein cholesterol (HDL-ch) level was significantly lower in the larger group than that in the smaller group. The prostatic anteroposterior size was significantly and positively related with age (r=0.31, p<0.0001), HOMA-IR (r=0.14, p=0.027), body mass index (r=0.10, p=0.049), S-BP (r=0.11, p=0.046) and D-BP (r=0.12, p=0.032) in all subjects. These data firstly indicated that metabolic syndrome was as a risk factor for developing BPH, secondly revealed that the transabdominal ultrasonography was able to use as the standard clinical tool for the useful assessment of prostatic size in daily medical health examinations.

収録刊行物

• 総合健診

  総合健診 33 (4), 474-478, 2006

  一般社団法人 日本総合健診医学会

キーワード

• Benign Prostatic Hyperplasia
• Prostatic Anteroposterior Size
• Metabolic Syndrome
• Transabdominal Ultrasonography
• Japanese Healthy Males

詳細情報

• CRID: 1390001205197364096
• NII論文ID: 130004062501
• NII論文ID: 10018040587
• NII書誌ID: AA11592031
• DOI: 10.7143/jhep.33.474
• ISSN: 18844103
• ISSN: 13470086
• Web Site: https://search.jamas.or.jp/link/ui/2007087125
• 本文言語コード: en
• データソース種別:
  • JaLC
  • Crossref
  • CiNii Articles
• 抄録ライセンスフラグ: 使用不可